Port City Dialysis Center is a medicare approved dialysis facility center in Stockton, California and it has 24 dialysis stations. It is located in San Joaquin county at 1810 S. Fresno Ave., Stockton, CA, 95206. You can reach out to the office of Port City Dialysis Center at (209) 946-0738. This dialysis clinic is managed and/or owned by Davita. Port City Dialysis Center has the following ownership type - Profit. It was first certified by medicare in March, 2017. The medicare id for this facility is 552808 and it accepts patients under medicare ESRD program.
Name | Port City Dialysis Center |
---|---|
Location | 1810 S. Fresno Ave., Stockton, California |
No. of Dialysis Stations | 24 |
Medicare ID | 552808 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
1810 S. Fresno Ave., Stockton, California, 95206 | |
(209) 946-0738 | |
Not Available |
NPI Number | 1437569514 |
Doing Business As | Coral Dialysis Llc |
Address | 1810 S Fresno Ave Stockton, California, 95206 |
Phone Number | (209) 946-0738 |
Dialysis patients with Hemoglobin data | 1 |
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 15 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 40 |
Percentage of adult patients getting regular hemodialysis at the center | 83 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Port City Dialysis Center with elevated calcium levels.
Patients with hypercalcemia | 15 |
Hypercalcemia patient months | 40 |
Patients with Serumphosphor | 16 |
Patients with Serumphosphor less than 3.5 mg/dL | 15 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 27 |
Patients with Serumphosphor greater than 7 mg/dL | 7 |
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 15 |
Patient months included in arterial venous fistula and catheter summaries | 35 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 71 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 26 |
RAI West March Location: 3115 West March Lane Suite A, Stockton, California, 95219 Phone: (209) 955-7527 |
RAI North California Location: 2350 N California Street, Stockton, California, 95204 Phone: (209) 943-0854 |
Delta Sierra Dialysis Center Location: 555 West Benjamin Holt Drive #200, Stockton, California, 95207 Phone: (209) 473-2294 |
Stockton Home Dialysis Center Location: 5608 North Pershing Ave, Stockton, California, 95207 Phone: (209) 954-9563 |
Wellbound Of Stockton Llc Location: 3555 Deer Park Drive Suite 140, Stockton, California, 95219 Phone: (209) 955-5630 |